HERGENROTHER PAUL J,BOOTHMAN DAVID A,BAIR JOSEPH S,CAO LIFEN,GAO JIMMING,HUANG XIUMEI,LUO XIUQUAN,MA XINPENG,MOORE ZACHARY R,PARKINSON ELIZABETH I
申请号：
IN10041/DELNP/2015
公开号：
IN2015DN10041A
申请日:
2015.10.27
申请国别(地区):
IN
年份:
2016
代理人:
摘要：
The therapies described herein can be selectively lethal toward a variety of different cancer cell types and cancer conditions in a subject. The combination therapies described herein can be useful for the management, treatment, control, or adjuncttreatment of diseases, where the selective lethality is beneficial in chemotherapeutic therapy, particularly where the disease is accompanied by elevated levels of NQOl
